Skip to content
Recall Observatory FDA recall evidence

Device product

TheraSphere(R) YTTRIUM-90 CLASS MICROSPHERE INJECTION TheraSphere¿ is indicated for radiation treatment or as a neoadjuvant to surgery or transplantation in patients with unresectable HCC who can have placement of appropriately positioned hepatic arterial catheters.

Z-0078-2017

September 21, 2015

Class II

Product summary

Firm
Biocompatibles U.K., Ltd.
Event
Event 75350
Status
Terminated
Classification
Class II
Quantity
64 doses
Official record key
device-enforcement:Z-0078-2017

Official wording

Reason: One mislabeled dose of TheraSphere¿ Y-90 Glass Microspheres, which was shipped to Hong Kong (total radioactivity incorrect). The product ws labeled as 10 GBq and the actual does was 5 GBq.

Code information: Lot 1599211, Expiry Date: 18SEP2015 (12 days after calibration)

Distribution pattern: Worldwide Distribution - US to CA, FL, IL, WI, IN, OR, PA, MA, NY, KY, TX, MI, MD, NV, WA, OH, MN, and Internationally to Germany, Turkey, Hong Kong, Italy, Portugal

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    mislabeled